Healy James (CIK 0001245624)

Latest company ownership

Shares held
3,467,156
Last filed at
Feb 8, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
3,401,544
Last filed at
Jul 6, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
NXTC - NextCure, Inc.
Role: 10% Owner
Shares held
2,671,856
Last filed at
Nov 19, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
BIOA - BioAge Labs, Inc.
Role: Director
Shares held
1,638,236
Last filed at
Sep 27, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
ATYR - aTYR PHARMA INC
Role: 10% Owner
Shares held
1,546,126
Last filed at
May 14, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
1,392,738
Last filed at
Jun 10, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q2 2025Q4
Shares held
1,252,308
Last filed at
Jan 31, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4
Shares held
1,226,514
Last filed at
Jun 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
598,002
Last filed at
Oct 13, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
SYBX - SYNLOGIC, INC.
Role: 10% Owner
Shares held
583,559
Last filed at
Oct 6, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
Shares held
535,869
Last filed at
Nov 12, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
NTRA - Natera, Inc.
Role: Director
Shares held
34,209
Last filed at
Sep 2, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
33,450
Last filed at
Sep 18, 2025
Confidence Score
47.2
2025Q4
Confidence Score History
2018Q3 2025Q4
Shares held
27,000
Last filed at
Feb 11, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4
Shares held
22,000
Last filed at
Jun 14, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
AMRN - AMARIN CORP PLC\UK
Role: Director
Shares held
20,548
Last filed at
Jul 13, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q1 2025Q4
Shares held
15,000
Last filed at
Jun 21, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
OCGN - Ocugen, Inc.
Role: 10% Owner
Shares held
14,569
Last filed at
Dec 10, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 16, 2025 Sep 18, 2025 Y-mAbs Therapeutics, Inc. Director Sell 35.0 -2,250,961 -100.00% ✗ $19.1M
Sep 27, 2024 Sep 27, 2024 BioAge Labs, Inc. Director Buy 100.0 +666,665 40.69% ✗ $12M
Jul 1, 2024 Jul 3, 2024 Rapport Therapeutics, Inc. Director Buy 87.5 +44,032 2.26% ✗ $1.1M
Jun 10, 2024 Jun 10, 2024 Rapport Therapeutics, Inc. Director Buy 100.0 +558,824 40.12% ✗ $9.5M
Jan 30, 2024 Jan 31, 2024 ArriVent BioPharma, Inc. Director Buy 100.0 +444,444 35.49% ✗ $8M
Dec 13, 2023 Dec 22, 2023 Natera, Inc. Director Sell 15.0 -644,000 -28.79% ✗ $37.8M
Feb 6, 2023 Feb 8, 2023 Vera Therapeutics, Inc. 10% Owner Buy 95.0 +285,714 8.98% ✗ $2M
Nov 16, 2022 Jan 18, 2023 Natera, Inc. Director Sell 47.5 -2,400 -0.08% ✗ $90.5K
Feb 10, 2022 Feb 14, 2022 Vera Therapeutics, Inc. 10% Owner Buy 95.0 +266,666 9.15% ✗ $4M
Sep 27, 2021 Sep 29, 2021 Coherus Oncology, Inc. Director Sell 16.3 -434,555 -86.11% ✗ $7.3M
Jul 22, 2021 Jul 26, 2021 Natera, Inc. Director Buy 62.5 +2,400 0.08% ✗ $271.2K
Jul 2, 2021 Jul 6, 2021 Jade Biosciences, Inc. 10% Owner Buy 100.0 +357,142 10.50% ✗ $5M
May 18, 2021 May 18, 2021 Vera Therapeutics, Inc. 10% Owner Buy 100.0 +727,272 33.25% ✗ $8M
Feb 9, 2021 Feb 9, 2021 Bolt Biotherapeutics, Inc. Director Buy 100.0 +450,000 19.53% ✗ $9M
Jun 1, 2020 Jun 3, 2020 Iterum Therapeutics plc 10% Owner Sell 20.0 -500,000 -28.96% ✗ $812.1K
Nov 15, 2019 Nov 19, 2019 NextCure, Inc. 10% Owner Buy 96.3 +150,000 5.95% ✗ $5.5M
Nov 12, 2019 Nov 12, 2019 Galera Therapeutics, Inc. 10% Owner Buy 100.0 +750,000 32.14% ✗ $9M
Oct 30, 2019 Nov 1, 2019 Y-mAbs Therapeutics, Inc. Director Buy 92.5 +90,000 4.28% ✗ $2.5M
Jun 28, 2019 Jul 2, 2019 Coherus Oncology, Inc. Director Sell 13.8 -360,000 -15.70% ✓ $8M
Jun 20, 2019 Jun 24, 2019 Coherus Oncology, Inc. Director Sell 18.8 -317,130 -12.15% ✓ $6.8M
May 22, 2019 May 24, 2019 Coherus Oncology, Inc. Director Sell 22.5 -257,870 -8.99% ✓ $5.3M
May 13, 2019 May 15, 2019 NextCure, Inc. 10% Owner Buy 100.0 +400,000 18.85% ✗ $6M
Sep 21, 2018 Sep 25, 2018 Y-mAbs Therapeutics, Inc. Director Buy 100.0 +500,000 31.17% ✗ $8M
Aug 29, 2018 Aug 31, 2018 Coherus Oncology, Inc. Director Sell 45.0 -25,000 -0.86% ✓ $512.5K
May 30, 2018 May 30, 2018 Iterum Therapeutics plc Director Buy 100.0 +500,000 40.77% ✗ $6.5M
Mar 11, 2016 Mar 15, 2016 PDS Biotechnology Corp Director Buy 100.0 +541,343 23.42% ✗ $4M
Oct 13, 2015 Oct 13, 2015 Aclaris Therapeutics, Inc. 10% Owner Buy 100.0 +409,090 21.76% ✗ $4.5M
Oct 6, 2015 Oct 8, 2015 PDS Biotechnology Corp Director Buy 100.0 +503,665 27.86% ✗ $5.4M
Oct 5, 2015 Oct 6, 2015 SYNLOGIC, INC. 10% Owner Buy 100.0 +1,146,983 62.75% ✗ $6M
May 12, 2015 May 14, 2015 aTYR PHARMA INC 10% Owner Buy 100.0 +320,000 20.70% ✗ $4.5M
Dec 8, 2014 Dec 10, 2014 Ocugen, Inc. 10% Owner Buy 100.0 +490,388 30.91% ✗ $5.5M
Nov 12, 2014 Nov 12, 2014 Coherus Oncology, Inc. Director Buy 100.0 +425,926 19.98% ✗ $5.8M
Apr 2, 2012 Apr 4, 2012 AMARIN CORP PLC\UK Director Sell 15.0 -2,000,000 -26.62% ✗ $22M
Mar 28, 2012 Mar 30, 2012 AMARIN CORP PLC\UK Director Sell 15.0 -1,000,000 -11.75% ✗ $11M